Install
Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
- 186articles · 30d
- 11+ hour agolatest article
- Aug 17, 2026earliest in window
- 90%with images
- 243avg words
- Medical 137
- Health & Wellness 101
- Economy, Business & Finance 79
- Health 74
- Business & Industrial 64
- Finance & Business 32
- Science & Technology 21
- News 14
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate
4+ day, 5+ hour ago (88+ words) Indian Pharma Post Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate Nanopharm, Aptar Pharma’s specialist inhalation development services business, will lead formulation development and device assessment for ACT-101, supporting Aceso’s clinical development roadmap Chasing Consistency:…...
Superluminal Medicines raises $60 million to push obesity drug into clinic
5+ day, 5+ hour ago (62+ words) Indian Pharma Post Superluminal Medicines raises $60 million to push obesity drug into clinic Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The complexity of compliance The…...
FibroBiologics bags US patent for Fibroblast-based wound healing
6+ day, 4+ hour ago (57+ words) The technology targets some of the most difficult wounds to heal Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership to accelerate lab-to-market translation Fosun Pharma announces…...
Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials
1+ week, 5+ day ago (85+ words) indianpharmapost.com Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials The results build on statistically superior outcomes reported at Week 36, when the combination outperformed Taltz alone on key disease and metabolic measures Chasing Consistency: Centralizing operations…...
Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push
1+ week, 5+ day ago (65+ words) Merida's lead drug candidate, MER511, is already being tested in a Phase 1 trial for Graves' disease and thyroid eye disease Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push Sun Pharma joins White House push on US drug pricing…...
DoP's second PRIP call offers up to Rs. 100 crore per project for pharma and MedTech innovation
2+ week, 1+ day ago (414+ words) Rs. 5,000-crore scheme invites applications from startups, MSMEs and industry across new medicines, biosimilars, novel medical devices and other priority areas The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, has announced the second call for applications under the…...
University of Toronto researchers develop tRNA approach to target genetic diseases
2+ week, 1+ day ago (652+ words) Engineered tRNA restores full-length protein production in cystic fibrosis models, opening the door to a potential new class of RNA therapeutics Researchers at the University of Toronto have developed a next-generation RNA therapeutic approach that could potentially treat a broad…...
Japan approves Bayer’s Hyrnuo for HER2-mutant lung cancer
2+ week, 5+ day ago (81+ words) Hyrnuo is the first targeted therapy approved in Japan for this indication that can be used regardless of the line of therapy AstraZeneca India receives ESG rating of 57 from CRISIL Pulnovo Medical enrolls first US patients in trial of PADN…...
AbbVie unveils new lung cancer data at 2026 WCLC
2+ week, 5+ day ago (86+ words) Indian Pharma Post AbbVie unveils new lung cancer data at 2026 WCLC AbbVie is also advancing telisotuzumab adizutecan (Temab-A), an investigational c-Met-directed ADC carrying a topoisomerase 1 inhibitor (Top1i) payload The Business of Genomics: Opportunities, Investments, and Innovation in India Chasing Consistency: Centralizing…...
India’s genomics leaders to join Indian Pharma Post E-Conference on August 26
2+ week, 6+ day ago (288+ words) Delegate registrations are open for a high-level discussion on how genomics is transforming healthcare from reactive treatment to predictive, preventive and personalised care Indian Pharma Post is bringing together leading executives and innovators from India’s genomics, diagnostics and precision medicine…...